Consistent Revenue GrowthMulti-year top-line growth indicates persistent demand for Sincere's medical instruments, supporting scale and revenue visibility. Steady sales expansion provides room to invest in product development and distribution, lowering execution risk and underpinning medium-term earnings resilience.

Free Cash Flow RecoveryA strong improvement in free cash flow that closely tracks net income signals higher earnings quality and genuine cash conversion. Durable FCF supports dividends, capex and debt paydown capacity, enhancing financial flexibility and reducing reliance on external financing over the medium term.

Improved Equity And Lower LeverageRising equity and a meaningful reduction in debt-to-equity strengthen the balance sheet and lower solvency risk. This improvement increases capacity for strategic investments and cushions operating cycles, improving the company's ability to fund growth and withstand industry downturns.

Bears Say

Modest Margins And 2025 Profit DipThin operating margins and a recent decline in net income despite higher revenue point to margin pressure or rising costs. Persistently modest profitability limits retained earnings for reinvestment, reduces cushioning against margin shocks, and constrains long-term return-on-capital improvement.

Sizable Remaining DebtAlthough leverage has improved, the outstanding debt stock remains significant relative to company size. This elevates interest expense sensitivity and refinancing risk, limiting strategic flexibility and increasing downside exposure if cash flows weaken or rates rise materially.

Operating Cash Flow VolatilityA drop in operating cash flow year-over-year suggests variability in cash conversion and potential working-capital strain. Persistent volatility would undermine FCF predictability, complicate capital allocation decisions, and could force higher reliance on debt or cutbacks to dividends/capex.

7782 FAQ

What was Sincere Co. LTD.’s price range in the past 12 months?

Sincere Co. LTD. lowest stock price was ¥456.00 and its highest was ¥899.00 in the past 12 months.

What is Sincere Co. LTD.’s market cap?

Sincere Co. LTD.’s market cap is ¥2.91B.

When is Sincere Co. LTD.’s upcoming earnings report date?

Sincere Co. LTD.’s upcoming earnings report date is May 20, 2026 which is in 73 days.

How were Sincere Co. LTD.’s earnings last quarter?

Sincere Co. LTD. released its earnings results on Feb 13, 2026. The company reported ¥2.56 earnings per share for the quarter, beating the consensus estimate of N/A by ¥2.56.

Is Sincere Co. LTD. overvalued?

According to Wall Street analysts Sincere Co. LTD.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Sincere Co. LTD. pay dividends?

Sincere Co. LTD. pays a Annually dividend of ¥17 which represents an annual dividend yield of 2.23%. See more information on Sincere Co. LTD. dividends here

What is Sincere Co. LTD.’s EPS estimate?

Sincere Co. LTD.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Sincere Co. LTD. have?

Sincere Co. LTD. has 6,862,200 shares outstanding.

What happened to Sincere Co. LTD.’s price movement after its last earnings report?

Sincere Co. LTD. reported an EPS of ¥2.56 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.808%.

Which hedge fund is a major shareholder of Sincere Co. LTD.?

Currently, no hedge funds are holding shares in JP:7782

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology